ZNF844
Zinc finger protein 844
Also known as: FLJ14959, ZN844_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q08AG5
- Gene
- ZNF844
- Ensembl
- ENSG00000223547
- Chromosome
- 19
- Canonical length
- 666 aa
- Protein class
- Cancer-related genes, Predicted intracellular proteins, Transcription factors
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
666 residues, UniProt reviewed canonical sequence.
>Q08AG5|ZNF844
1 MDLVAFEDVA VNFTQEEWSL LDPSQKNLYR EVMQETLRNL ASIGEKWKDQ NIEDQYKNPR
61 NNLRSLLGER VDENTEENHC GETSSQIPDD TLNKKTSPGV KSCESSVCGE VFVGHSSLNR
121 HIRADTAHKP SEYQEYGQEP YKCQQRKKAF RCHPSFQMQE KAHTGEKLYD CKECGKTFIS
181 HSSIQRHMIM HNGDGTYKCK FCGKACPCLS IYLIHERVHT GEKPYKCKQC GKAFSYSTSL
241 QIHERTHTGE KPYECKECGK AFGSPNSLYE HRRTHTGEKP YECKQCGKAF RWFHSFQIHE
301 RTHSEEKAYE CTKCGKAFKC PSYLCRHEVT HSGKKPCECK QCGKALSYLN FQRHMKMHTR
361 MRPYKCKTVE KPLILPVRFE DMKELTLERN LMNASTVVKP SIVPVPFTIM KGLTLERNPM
421 NVSSVVKPSF LPLPFDIMKG LTLERNRMSV SNVGKPSDLP HTFKCMEGLT LKRNPMNVSS
481 VVKPSFFPLP FDIMKGLTLE RNPMSVSNVG KPSHLPHTFK CMKGLTLESN CMNLNNVKKP
541 LDLSETFKFM KRHTLERNPI RNMEKHSTIS LPFKYMQQCT EDRMPMNVKS VTKHSYLPRS
601 FEYMQEHTLE RNPMNVRNAE KRSIIFLLCV YTKGCTLERN HINVRIVGKH SVCLVPFVDI
661 KGLTLELocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF844 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 11 nTPM
Expression across tissuesHPA
Tissue
- retina: 11 nTPM
- thyroid gland: 7.1 nTPM
- parathyroid gland: 6.7 nTPM
- kidney: 6.4 nTPM
- ovary: 6 nTPM
- heart muscle: 4.9 nTPM
Single-cell type
- distal convoluted tubule cells: 35 nCPM
- loop of henle epithelial cells: 32 nCPM
- proximal tubule cells: 32 nCPM
- choroid plexus epithelial cells: 26 nCPM
- renal connecting tubule cells: 25 nCPM
- renal collecting duct intercalated cells: 24 nCPM
Immune cell
- basophil: 3.1 nTPM
- neutrophil: 1.8 nTPM
- eosinophil: 1.2 nTPM
- intermediate monocyte: 0.8 nTPM
- NK-cell: 0.7 nTPM
- memory B-cell: 0.6 nTPM
Brain region
- cerebellum: 20 nTPM
- white matter: 17 nTPM
- choroid plexus: 13 nTPM
- basal ganglia: 13 nTPM
- medulla oblongata: 12 nTPM
- thalamus: 12 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.79
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.32
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF844 as an antibody target. Whether an autoantibody or antibody against ZNF844 could matter depends on whether native ZNF844 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF844 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF844 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...